Derivados de beta-aminoácidos para tratamento de diabetes

摘要

Novel heterocyclic compounds of the formula I in which R1, R2, R2', R2'', R3, R4, R5, R6, R7 and R8 have the meanings indicated in Claim 1, are activators of glucokinase and can be used for the prevention and/or treatment of Diabetes Typ 1 and 2, obesity, neuropathy and/or nephropathy.